“Patient-Reported Outcomes With Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body in the Phase 3 ARRECTOR Trial”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 2, Mar. 2025, p. s525, https://doi.org/10.25251/skin.10.supp.525.